The Cigna Group said director Donna F. Zarcone informed its Board of Directors that she will retire from the Board effective December 31, 2026. The company stated that her retirement is not the result of any disagreement with the company.
The Cigna Group introduced its “Lead to One” vision at Investor Day, focusing on affordability and personalized care across the health care continuum. Company leaders described applying the capabilities of Evernorth Health Services and Cigna Healthcare to complex-care needs, and using data, clinical expertise and AI to identify needs earlier and personalize support. The company reaffirmed its 2026 financial guidance and set a long-term average annual adjusted EPS growth target of 10%-14%.
It announced a $3 billion multi-year series of modernization and productivity initiatives focused on streamlining processes, AI-enabled tools, and supplier and vendor management. Ann M. Dennison, executive vice president and chief financial officer, said the initiatives are expected to self-fund and fuel performance. The Cigna Group Foundation announced a $10.5 million, three-year grant program to expand community support for patients and caregivers and address non-clinical treatment barriers, including through care navigation, education and peer support. The company’s outlook includes expected future share repurchases and anticipated 2026 dividends; future dividend declarations are subject to Board approval.
Cigna Group (CI) reported that executive vice president and special advisor to the CEO Everett Neville sold 617 shares of common stock on September 3, 2026 in an open-market or private transaction at $284.05 per share, pursuant to a Rule 10b5-1 trading plan adopted on June 2, 2026. Following this sale, he directly holds 5,053 shares of Cigna Group common stock.
Cigna Group (CI) reports that President and Chief Executive Officer Brian C. Evanko received equity awards on September 1, 2026. He was granted 6,716 stock options with an exercise price of $281.1325 per share and a separate award of 3,113 restricted shares, both vesting in three equal annual installments beginning September 1, 2027. Following these grants, he holds 41,030 common shares directly, plus indirect holdings of 25,614 shares through a GRAT and 919.5791 shares through Cigna’s 401(k) Plan. No Rule 10b5-1 trading plan is reported.
Cigna Group (CI) has a planned sale of common stock reported under Rule 144 for the account of officer Neville Everett. The notice covers 617 shares of common stock that were acquired through restricted stock vesting from the issuer as compensation on March 1, 2026, with an intended sale date around September 3, 2026 and an indicated aggregate value of $175,258.85.
Cigna Group (CI) director George Kurian reported an acquisition of 108.6642 phantom stock units on August 31, 2026 under the company’s director Deferral Plan, increasing his directly held phantom stock balance to 2,041.8523 units. These units represent voluntary deferral of a portion of his cash retainer into a hypothetical stock fund and are economically equivalent to Cigna common shares but will be settled in cash.
Cigna Group (CI) reported that executive Bryan Holgerson received small additional awards of phantom stock units linked to Cigna common stock. On 2026-07-09, 2026-07-23, and 2026-08-06 he acquired 0.8873, 0.9458, and 0.9837 units, respectively, under the Executive Deferred Compensation Plan, which are economically equivalent to CI shares but will be settled in cash. He also reports indirect ownership of 735.9274 CI common shares held through The Cigna Group's 401(k) Plan.
Cigna Group (CI) executive Nicole S. Jones, EVP, Chief Administrative Officer and Chief Human Resources Officer, reported selling 2,677 shares of common stock on 2026-08-18 at $279.61 per share in an open-market transaction pursuant to a Rule 10b5-1 trading plan adopted on May 4, 2026. After this sale, she directly holds 25,880 shares and indirectly holds 1,451.2364 shares through participation in The Cigna Group's 401(k) Plan.
Cigna Group (CI) insider Nicole S. Jones filed a Rule 144 notice covering planned sales of common stock. The filing lists a planned stock option exercise and potential sale of 2,677 shares of Cigna common stock on 08/18/2025, for cash, through Fidelity Brokerage Services LLC. It also reports that during the past three months, Jones sold 19,436 shares of Cigna common stock for aggregate proceeds of $5,369,583.72.
The Cigna Group executive Nicole S. Jones, EVP and Chief Administrative and Chief Human Resources Officer, exercised 15,346 employee stock options at $192.02 per share on August 4–5, 2026, receiving common stock.
She also sold 19,436 common shares at $276.27 per share on August 4, 2026. All trades were made under a Rule 10b5-1 trading plan adopted May 4, 2026. As of August 4, 2026, she reported 1,451.2364 shares held indirectly through The Cigna Group's 401(k) Plan.